Singapore markets open in 5 hours 6 minutes

Straits Times Index
3,289.42
-23.93(-0.72%)
S&P 500
5,306.07
+59.39(+1.13%)
Dow
39,895.02
+336.91(+0.85%)
Nasdaq
16,737.19
+226.01(+1.37%)
Bitcoin USD
66,122.35
+4,508.24(+7.32%)
CMC Crypto 200
1,390.55
+122.61(+9.67%)

GILD May 2024 68.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.6900

-0.1300

(-15.85%)

As of 02:27PM EDT. Market open.

Business Wire
Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
SANTA MONICA, Calif., May 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced 12 abstracts from its industry-leading Chimeric Antigen Receptor (CAR) T-cell therapy portfolio at the upcoming 2024 European Hematology Association (EHA) Annual Congress, June 13-16, Madrid, Spain.
Yahoo Finance
One stock is dragging down the S&P 500's earnings growth
S&P 500 companies have had a solid Q1 earnings season, with one key exception: drugmaker Bristol Myers Squibb.
Zacks
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.